mg kg intravenously

Related by string. * MGD . mgd . Mg . MGs . MGS . mgs : Yard Freestyle =-#.# mg dL . mg kg dose . mg tablets . kilogram mg kg . mg sodium . mg QD / kgs . Kgs . KGS . Kg . KGD : Krishna Godavari KG basin . KG basin . KG Basin . ¢ kg cwt . mg kg / : intravenously administered . administered intravenously . fluids intravenously . palifosfamide administered intravenously . mg kg administered intravenously * *

Related by context. Frequent words. (Click for all words.) 62 mcg kg 57 subcutaneous injections 57 mg/m2 56 mg dose 55 inactive placebo 55 mg BID 55 milligram doses 55 peginterferon alfa 2a 54 intravenous infusion 54 IU mL 54 mg m 53 epoetin alfa 53 ketoconazole 53 hypokalemia 53 mg kg 53 mitoxantrone 53 LIALDA 52 mg doses 52 mcg 52 plus ribavirin 52 ORENCIA 52 milligrams mg 51 μg 51 dose cohorts 51 adalimumab 51 mg d 51 postoperatively 50 peginterferon alfa 2b 50 mesalamine 50 adefovir 50 dosed 50 peginterferon 50 JANUVIA 50 FOLFOX 50 50 sitagliptin 50 titrated 50 mg 50 fluticasone 49 administered orally 49 dose regimens 49 n = 49 intravenous infusions 49 events AEs 49 monotherapy 49 placebo p = 49 STELARA 49 Lantus R 49 budesonide 49 fluorouracil 48 subcutaneously 48 discontinuations due 48 randomized #:# 48 placebo p 48 Taxotere R 48 zoledronic acid 48 ceftriaxone 48 dexamethasone 48 mg mL 48 dosing 48 febrile neutropenia 48 unfractionated heparin 48 placebo 48 HbA1c levels 48 milligram dose 48 lamotrigine 48 ONGLYZA 47 azathioprine 47 Median survival 47 SPRYCEL 47 etanercept 47 alendronate 47 rotigotine 47 microgram dose 47 median PFS 47 decitabine 47 vinorelbine 47 tiotropium 47 leukopenia 47 g dL 47 #mg [003] 47 interferon alfa 47 nasopharyngitis 47 administered intravenously 47 #.#mg [004] 47 FOSRENOL 46 treatment emergent adverse 46 Adverse events 46 esomeprazole 46 pegylated interferon 46 subcutaneous injection 46 evaluable 46 primary efficacy endpoint 46 severe renal impairment 46 bupivacaine 46 SEROQUEL XR 46 dosing regimen 46 Hepsera 46 NEXIUM 46 evaluable patients 46 exenatide

Back to home page